Volume 25, Number 10—October 2019
Control and Elimination of Extensively Drug-Resistant Acinetobacter baumanii in an Intensive Care Unit
|Sequence type, no. (%)¶|
|New STs, 1200–1206||0||6 (35.3)|
*Bold indicates statistical significance. ESBL, extended-spectrum beta-lactamase; ICU, intensive care unit; MLST, multilocus sequence typing; PCR, polymerase chain reaction; ST, sequence type.
†During February 1, 2016–June 30, 2016, ICU patients received colistin/carbapenem therapy for A. baumannii infections.
‡During July 1, 2016–January 31, 2017, ICU implemented carbapenem-sparing regimen for A. baumannii infections.
§Determined by PCR.
¶Determined by multilocus sequence typing.
1These authors contributed equally to this article.